Increased revenue by 31% year-over-year, driven by growth in CTV plus increased adoption of personalization
Grew CTV revenue by 48% year-over-year
CTV accounted for 45% of total 2021 revenue, up from 40% in 2020
Achieved adjusted EBITDA* of $5.4 million reflecting 110% growth year-over-year
Agreed to acquire converged TV measurement leader TVSquared to enhance measurement capabilities and expand serviceable market

NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Innovid Corp. (NYSE:CTV), a leading independent connected TV (CTV) advertising delivery and measurement platform, today announced financial results for the fourth quarter and fiscal year 2021 ended December 31, 2021.

"2021 was a milestone year for Innovid, from becoming a publicly traded company to consistently growing our revenue in the connected TV space. We expanded our client base and achieved record-high retention rates despite the headwinds in ad spend across the industry," said Zvika Netter, Co-Founder and Chief Executive Officer of Innovid. "As we look at the coming year, the recently announced acquisition of TVSquared is expected to further expand our presence in the fast-growing global TV ad measurement space, as part of our long term strategy to provide a comprehensive and measurable solution for converged TV."

Fourth Quarter and Full Year 2021 Financial Highlights:

Revenue for the fourth quarter and full year 2021 was $26.0 million and $90.3 million respectively, reflecting 13% and 31% growth year-over-year.
Gross margin in the fourth quarter was 79%, and 80% for full year 2021.
Net loss was $(7.6) million or $(0.59) per share in Q4,and $(11.5) million or $(3.31) per share for the full year of 2021.
Adjusted EBITDA* was $1.8 million in the fourth quarter and $5.4 million in the full year of 2021, reflecting 71% decline and 110% growth year-over-year, respectively.
Cash and cash equivalents as of December 31, 2021 were $157 million.

Fourth Quarter and 2021 Business Highlights Include:

Consistent revenue growth: Revenue for full-year 2021 totaled $90.3 million, an increase of 31% compared to 2020, driven primarily by 48% growth in CTV revenue. CTV accounted for 45% of total revenue generated by Innovid during the 2021 fiscal year, up from 40% in 2020.
Strong customer retention: Total number of core clients grew from 95 to 109. Annual core platform clients experienced record-high retention rates of 97%, up from 94% in 2020, and net revenue retention of 127% up from 121% in 2020.
Advanced personalized creative adoption: Premium-priced advanced creative revenue grew 49% year-over-year in 2021.
Expanded geographically: In Q4, Innovid expanded capabilities into China, the world's second-largest media market, growing its global footprint to over 75 countries. Total 2021 international volume, derived outside the U.S. market, grew 39% year-over-year in 2021. CTV international revenue, grew 137% year-over-year.
Continued bolstering of CTV infrastructure: CTV-focused cross-industry collaborations and expanded partnerships in 2021 included:
- CTV fraud protection: Strengthened integrations with DoubleVerify and Integral Ad Science, designed to ensure strong, seamless CTV fraud protection.
- Interactive CTV at scale: Partnered with The Trade Desk, Magnite, and others to create a consortium, organizing the leading buy-side and sell-side programmatic platforms within Innovid's infrastructure, to deliver interactive CTV creative at scale.
- Exclusive NBC Olympics ad delivery partnership: Exclusively selected by NBCU to support third-party ad serving across their leading CTV apps becoming the first and only third-party ad server to be used during any NBC Olympics broadcast.
- CTV reach & frequency benchmarks: Collaborated with the Association of National Advertisers (ANA) and 20 leading advertisers, to publish a deep-drive report into new CTV KPIs, benchmarks, and best practices.
Introduced leading identity solution and partnerships:
- Innovid Key launch: In Q3, launched Innovid Key, an industry leading infrastructure approach to identity management designed to enhance cross-screen targeting and measurement.
- LiveRamp integration: Also in Q3, expanded the identity integration between Innovid Key and LiveRamp's RampID, enabling brands such as Molson Coors to deliver 55% higher audience addressability for CTV.
- OpenAP partnership: In Q4, selected by OpenAP, the advanced advertising company, as digital partner for their XPm cross-platform measurement framework.

First Quarter and Full Year 2022 Outlook:

Innovid is providing the following financial guidance for the first quarter of 2022:

Revenue is expected to be in the range of $21 million and $22 million, a year-over-year increase of approximately 17% to 22% year-over-year.
Adjusted EBITDA is expected to be in the range of minus $4.5 million to minus $3.5 million.

Innovid is providing the following financial guidance for the full-year 2022:

Revenue in the range of $110 million and $115 million, a year-over-year increase of approximately 22% to 28% year-over-year.
Adjusted EBITDA is expected to be positive.

Innovid is not able to provide a reconciliation of the projected adjusted EBITDA to expected net income (loss) attributable to Innovid, the most directly comparable GAAP measure, without unreasonable effort, due to the unknown effect, timing, and potential significance of the effects of taxes on income in multiple jurisdictions, finance expenses including valuations, among others. These items have in the past, and may in the future, significantly affect GAAP results in a particular period.

We define a core client as an advertiser that generates at least $100,000 of annual revenue. Core platform client is a core client that uses our platform for personalization services and /or as an ad server of record.

*See Use of Non-GAAAP Financial Information and Reconciliation of GAAP to Non-GAAP Financial Measures table.

Conference Call

The financial results, the TV Squared acquisition and business highlights will be discussed on a conference call and webcast today at 8:30 a.m. Eastern Time. Speakers will include Zvika Netter, Co-founder and Chief Executive Officer, Tanya Andreev-Kaspin, Chief Financial Officer and Tal Chalozin, co-founder and Chief Technology Officer.

A live webcast of the call can be accessed from Innovid's Investor Relations website at https://investors.innovid.com/. An archived webcast of the conference call will also be made available on the Innovid website following the call. The live call may also be accessed via telephone at (877) 407-0833 toll-free and at (201) 389-0862 internationally.

A telephonic replay of the conference call will be available until May 25, 2022 following the end of the conference call. To listen to the replay, please dial (877) 660-6853 or (201) 612-7415, access ID: 13726425.

Use of Non-GAAP Financial Information

Included within this press release are the non-GAAP financial measures such as Adjusted EBITDA, Non-GAAP net income and Non-GAAP diluted EPS that supplement the Consolidated Statements of Income of Innovid prepared under generally accepted accounting principles (GAAP). Adjusted EBITDA is earnings before depreciation and amortization, stock-based compensation, interest expense (income), net, and provision for (benefit from) income taxes. Non-GAAP net income excludes charges and the related income tax effects for stock-based compensation. Tax rates on the tax-deductible portions of the stock-based compensation expense approximating X% to X% have been used in the computation of non-GAAP net income and non-GAAP diluted EPS. Reconciliations of GAAP to non-GAAP amounts for the periods presented herein are provided in schedules accompanying this release and should be considered together with the Consolidated Statements of Income. These non-GAAP measures are not meant as a substitute for GAAP, but are included solely for informational and comparative purposes. The Company's management believes that this information can assist investors in evaluating the Company's operational trends, financial performance, and cash generating capacity. Management believes these non-GAAP measures allow investors to evaluate the Company's financial performance using some of the same measures as management. However, the non-GAAP financial measures should not be regarded as a replacement for or superior to corresponding, similarly captioned, GAAP measures and may be different from non-GAAP financial measures used by other companies.

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1996. The Company's actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," "aim," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's expectations regarding its future financial results, expected growth and the expected benefits resulting from its partnerships. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results, including Innovid's ability to raise financing in the future, success in retaining or recruiting officers, key employees or directors, changes in applicable laws or regulations, Innovid's ability to maintain and expand relationships with advertisers, decreases and/or changes in CTV audience viewership behavior, Innovid's ability to make the right investment decisions and to innovate and develop new solutions, the accuracy of Innovid's estimates of market opportunity, forecasts of market growth and projections of future financial performance, the extent of investment required in Innovid's sales and marketing efforts, Innovid's ability to effectively manage its growth, the impact of the coronavirus pandemic, acquisition related risks, and other important factors discussed under the caption "Risk Factors" in Innovid's prospectus on Form 424(b)(3) filed with the SEC on December 30, 2021, as such factors may be updated from time to time in its other filings with the SEC, accessible on the SEC's website at www.sec.gov and the Investors Relations section of Innovid's website at investors.innovid.com. You should carefully consider the risks and uncertainties described in the documents filed by the Company from time to time with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Most of these factors are outside the Company's control and are difficult to predict. The Company cautions not to place undue reliance upon any forward-looking statements, including projections, which speak only as of the date made. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.

About Innovid

Innovid powers connected TV (CTV) advertising streaming, personalization, and measurement for the world's largest brands. Through a global infrastructure that enables data-driven personalization, real-time decisioning, scaled ad serving, and accredited measurement, Innovid offers its clients and partners streamlined solutions that optimize the value of advertising investments across screens and devices. Innovid is an independent platform that leads the market in CTV innovation, powered proprietary technology and exclusive partnerships designed to fuel the future of TV advertising.

Headquartered in New York City, Innovid serves a global client base through offices across the Americas, Europe, and Asia Pacific. To learn more, visit innovid.com or follow us on LinkedIn or Twitter.

Investor Relations Contact

Miri Segal-Scharia

ir@innovid.com

Media Contact

Chris Harihar

Crenshaw Communications

chris@crenshawcomm.com

646-535-9475

INNOVID, INC. AND ITS SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except stock and per stock data)

	December 31,
		2021			2020
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	156,696		$	15,645
Trade receivables, net (allowance for doubtful accounts of $81 and $121 at December 31, 2021 and 2020, respectively)		35,422			34,804
Prepaid expenses and other current assets		3,131			1,174
Total current assets		195,249			51,623
NON-CURRENT ASSETS:
Long-term deposit		310			348
Long-term restricted deposits		462			447
Property and equipment, net		4,840			2,325
Goodwill		4,555			4,555
Intangible assets, net		—			33
Other non-current assets		116			127
Total non-current assets		10,283			7,835
TOTAL ASSETS	$	205,532		$	59,458
LIABILITIES, TEMPORARY EQUITY, AND STOCKHOLDERS' EQUITY ( DEFICIT)
CURRENT LIABILITIES:
Trade payables		5,026			1,854
Employees and payroll accruals		7,742			6,506
Accrued expenses and other current liabilities		3,082			1,155
Current portion of long-term debt		6,000			1,527
Total current liabilities		21,850			11,042
NON-CURRENT LIABILITIES:
Long-term debt		—			7,506
Other non-current liabilities		3,455			3,144
Warrants liability		18,972			499
Total non-current liabilities		22,427			11,149
TOTAL LIABILITIES		44,277			22,191

TEMPORARY EQUITY
Preferred stocks - Authorized: 500,000 and 74,236,896 at December 31, 2021 and 2020, respectively; Issued and Outstanding: 0 and 73,690,340 at December 31, 2021 and 2020, respectively		—			86,997
STOCKHOLDERS' EQUITY (DEFICIT):
Common stocks of $0.0001 par value - Authorized: 500,000,000 and 100,634,071 at December 31, 2021 and 2020, respectively; Issued: 119,017,380 and 18,189,937 at December 31, 2021 and 2020, respectively; Outstanding: 119,017,380 and 16,275,609 at December 31, 2021 and 2020, respectively		12			2
Treasury stocks, at cost (0 stocks at December 31, 2021 and 2020)		—			(1,629	)
Additional paid-in capital		293,719			10
Accumulated deficit		(132,476	)		(48,113	)
Total stockholders' equity (deficit)		161,255			(49,730	)
TOTAL LIABILITIES, TEMPORARY EQUITY, AND STOCKHOLDERS' EQUITY (DEFICIT)	$	205,532		$	59,458

INNOVID, INC. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except stock and per stock data)

	Three months ended December 31,						Year ended December 31,
	(Unaudited)			(Unaudited)
		2021			2020			2021			2020
Revenues	$	25,967		$	23,029		$	90,291		$	68,801
Cost of revenues		5,367			3,821			17,785			12,365
Gross profit		20,600			19,208			72,506			56,436
Operating expenses:
Research and development		7,687			4,610			24,619			18,283
Sales and marketing		9,522			6,186			33,056			28,810
General and administrative		10,093			2,599			20,680			8,221
Total operating expenses		27,302			13,395			78,355			55,314
Operating (loss) profit		(6,702	)		5,813			(5,849	)		1,122
Finance expenses, net		508			206			4,386			734
(Loss) income before taxes		(7,210	)		5,607			(10,235	)		388
Taxes on income		408			301			1,237			1,200
Net (loss) income		(7,618	)		5,306			(11,472	)		(812	)

Accretion of preferred stock to redemption value		(24,070	)		(3,424	)		(77,063	)		(7,297	)
Net (loss) gain attributable to common stockholders	$	(31,688	)	$	1,882		$	(88,535	)	$	(8,109	)
Net (loss) gain per stock attributable to common stockholders –
Basic	$	(0.59	)	$	0.06		$	(3.31	)	$	(0.51	)
Diluted	$	(0.59	)	$	0.06		$	(3.31	)	$	(0.51	)
Weighted-average number of stocks used in computing net (loss) gain per stock attributable to common stockholders
Basic		53,898,933			16,077,628			26,745,020			16,028,560
Diluted		53,898,933			92,744,563			26,745,020			16,028,560

STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY (DEFICIT)

(In thousands, except stock data)

	Temporary equity					Common stocks					Treasury stocks					Additional paid-in capital			Accumulated deficit			Total stockholders' equity (deficit)
	Number		Amount			Number		Amount			Number		Amount			Additional paid-in capital			Accumulated deficit			Total stockholders' equity (deficit)
Balance as of January 1, 2020	55,105,773		$	79,700		11,941,841		$	12		1,431,538		$	(1,629	)	$	3,048		$	(44,218	)	$	(42,787	)
Retroactive application of Exchange Ratio	18,584,567			—		4,027,419			(10	)	482,790			—			10			—			—
Balance as of January 1, 2020 as adjusted***	73,690,340		$	79,700		15,969,260		$	2		1,914,328		$	(1,629	)	$	3,058		$	(44,218	)	$	(42,787	)
Accretion of preferred stocks to redemption value	—			7,297		—			—		—			—			(4,214	)		(3,083	)		(7,297	)
Capital contribution	—			—		—			—		—			—			504			—			504
Stock-based compensation	—			—		—			—		—			—			584			—			584
Stock options exercised	—			—		306,349		*)			—			—			78			—			78
Net loss	—			—		—			—		—			—			—			(812	)		(812	)
Balance as of December 31, 2020 as adjusted***	73,690,340		$	86,997		16,275,609		$	2		1,914,328		$	(1,629	)	$	10		$	(48,113	)	$	(49,730	)
Accretion of preferred stocks to redemption value	—			77,063		—			—		—			—			(4,172	)		(72,891	)		(77,063	)
Conversion of redeemable convertible preferred stock into common stock	(73,690,340	)		(164,060	)	73,690,340			7		—			—			164,053			—			164,060
Reverse recapitalization, net	—			—		32,039,826			3		—			—			194,878			—			194,881
Conversion of Legacy Innovid Warrants	—			—		507,994		*)			—			—			5,080			—			5,080
Secondary Sale Amount	—			—		(6,885,486	)	*)			—			—			(68,855	)		—			(68,855	)
Warrant exercised**	—			—		132,392		*)			—			—			—			—			—
Treasury stock derecognized	—			—		—			—		(1,914,328	)		1,629			(1,629	)		—			—
Stock-based compensation	—			—		—			—		—			—			3,273			—			3,273
Stock options exercised	—			—		3,256,705		*)			—			—			1,081			—			1,081
Net loss	—			—		—			—		—			—			—			(11,472	)		(11,472	)
Balance as of December 31, 2021 as adjusted***	—		$	—		119,017,380		$	12		—		$	—		$	293,719		$	(132,476	)	$	161,255

* Represents an amount less than $1.

** The warrant was exercised in November 2021 and was net share settled.

*** The number of shares was retroactively adjusted for the Transaction.

INNOVID, INC. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, except stock and per stock data)

	Year ended December 31,
		2021			2020
Cash flows from operating activities:
Net loss	$	(11,472	)	$	(812	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		661			730
Stock-based compensation		3,273			584
Loss on sale of property and equipment		—			127
Change in fair value of warrants		762			86
Founders notes forgiven		459			—
Non-cash interest expense		—			22
Changes in operating assets and liabilities
Increase in trade receivables, net		(618	)		(8,372	)
(Increase)/ decrease in prepaid expenses and other assets		(2,282	)		78
Increase/ (decrease) in trade payables		1,500			(545	)
Increase in employees and payroll accruals		1,236			1,914
Increase in accrued expenses and other liabilities		851			2,029
Net cash used in operating activities		(5,630	)		(4,159	)
Cash flows from investing activities:
Internal use software capitalization		(2,594	)		—
Purchase of property and equipment		(549	)		(1,030	)
Proceeds from sale of property and equipment		—			6
(Increase)/ decrease in deposits		(85	)		76
Net cash used in investing activities		(3,228	)		(948	)
Cash flows from financing activities:
Proceeds from the Transaction, net		220,857			—
Payment for Secondary Sale Transaction		(68,855	)		—
Capital contributions		—			504
Proceeds from loans		—			15,516
Loan repayment		(3,033	)		(6,504	)
Repayment of acquisition liability		(126	)		(592	)
Proceeds from exercise of options		1,081			78
Net cash provided by financing activities		149,924			9,002
Increase in cash, cash equivalents and restricted cash		141,066			3,895
Cash, cash equivalents and restricted cash at the beginning of the year		16,092			12,197
Cash, cash equivalents and restricted cash at the end of the year	$	157,158		$	16,092
Supplemental disclosure of cash flows activities:
(1) Cash paid during the year for:
Income taxes	$	277		$	308
Interest	$	251		$	272
(2) Non-cash transactions:
Company Warrants received as part of the Transaction	$	22,791		$	—
Accrued acquisition liability	$	—		$	126
Accretion of preferred stocks to redemption value	$	77,063		$	7,297
Accrued transaction cost, not yet paid	$	3,185		$	—

Reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position
Cash and cash equivalents		156,696			15,645
Long-term restricted deposits		462			447
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	157,158		$	16,092

INNOVID, INC. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, except stock and per stock data)

Key Metrics and Non-GAAP Financial Measures

Adjusted EBITDA

In addition to our results determined in accordance with U.S. GAAP, we believe that certain non-GAAP financial measures, including Adjusted EBITDA and Adjusted EBITDA Margin, are useful in evaluating our business. We calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by total revenue. The following table presents a reconciliation of Adjusted EBITDA, a non-GAAP financial measure, to the most directly comparable financial measure prepared in accordance with GAAP.

	Three months ended December 31,				Year ended December 31,
	2021		2020		2021		2020
Net (loss)/income	(7,618	)	5,306		(11,472	)	(812	)
Net loss margin	(29)%		23	%	(13)%		(1)%
Depreciation and amortization	174		255		661		730
Stock-based compensation	962		127		3,273		584
Finance expense, net (a)	508		206		4,386		734
Transaction related expenses (b)	7,200		—		7,200		—
Acquisition related expenses (c)	161		—		161		—
Other (d)	—		—		—		153
Taxes on income	408		301		1,237		1,200
Adjusted EBITDA	1,795		6,195		5,446		2,589
Adjusted EBITDA margin	7	%	27	%	6	%	4	%

(a) Finance expense, net consists mostly of remeasurement expense related to our Argentinian subsidiary's monetary assets, liabilities and operating results, our interest expense, revaluation of our warrants and transaction costs allocated to warrants.

(b) Transaction related expenses consists of one-time, non-recurring bonus payments to certain members of management, professional fees associated with the SPAC merger transaction and SEC filings.

(d) Other consists predominantly of the loss related to a one-time loss from sale of fixed assets in our Israel subsidiary.

We use Adjusted EBITDA and Adjusted EBITDA Margin as measures of operational efficiency to understand and evaluate our core business operations. We believe that these non-GAAP financial measures are useful to investors for period to period comparisons of our core business and for understanding and evaluating trends in our operating results on a consistent basis by excluding items that we do not believe are indicative of our core operating performance.

These non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for an analysis of our results as reported under GAAP. Some of the limitations of these measures are:

they do not reflect changes in, or cash requirements for, our working capital needs;
Adjusted EBITDA does not reflect our capital expenditures or future requirements for capital expenditures or contractual commitments;
they do not reflect costs of acquiring and integrating businesses, which will continue to be a part of our growth strategy;
they do not reflect one-time, non-recurring bonus costs and third party costs associated with the SPAC merger transaction and regulatory filings.
they do not reflect income tax expense or the cash requirements to pay income taxes;
they do not reflect our interest expense or the cash requirements necessary to service interest or principal payments on our debt; and
although depreciation and amortization are non-cash charges related mainly to intangible assets, certain assets being depreciated and amortized will have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements.

In addition, other companies in our industry may calculate these non-GAAP financial measures differently than we do, limiting their usefulness as a comparative measure. You should compensate for these limitations by relying primarily on our U.S. GAAP results and using the non-GAAP financial measures only supplementally. We calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by total revenue.

Innovid Reports Q4 and Fiscal Year 2021 Financial Results